Prevention of amputation by neoadjuvant therapy with pembrolizumab in acrolentiginous melanoma.
J Eur Acad Dermatol Venereol
; 38(9): e820-e822, 2024 Sep.
Article
in En
| MEDLINE
| ID: mdl-38421077
Full text:
1
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Neoadjuvant Therapy
/
Antibodies, Monoclonal, Humanized
/
Amputation, Surgical
/
Melanoma
Limits:
Humans
Language:
En
Journal:
J Eur Acad Dermatol Venereol
Journal subject:
DERMATOLOGIA
/
DOENCAS SEXUALMENTE TRANSMISSIVEIS
Year:
2024
Type:
Article
Affiliation country:
Germany